The firm recently presented data on its first two products that use its proprietary 3Base technology.
The new distribution partnership will allow JN Medsys to expand into Malaysia and accelerate distribution in its Singapore base.
The new funding will be used to further develop the firm's method of enriching signal processing on existing qPCR instruments.
The company's second quarter revenue growth was driven in part by strong sales from its life science segment.
The company has aspirations for a combined molecular/immunoassay platform, but plans to go to market with a 22-target real-time PCR-enabled syndromic panel.
A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.
Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.
Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.
In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.